Location History:
- San Jose, CA (US) (2020)
- Sunnyvale, CA (US) (2013 - 2021)
- Stanford, CA (US) (2022)
Company Filing History:
8 out of 5,313 
4 out of 5 
1 out of 1 Years Active: 2013-2022
Title: Innovations of Yu Rebecca Miao
Introduction
Yu Rebecca Miao is a prominent inventor based in San Jose, California. She has made significant contributions to the field of biotechnology, particularly in the development of novel therapeutic proteins. With a total of eight patents to her name, Miao's work has the potential to impact cancer treatment and other medical applications.
Latest Patents
Among her latest patents is the SPD-1 variant# FC fusion proteins, which focuses on novel sPD-1 variant—Fc fusion proteins. This invention aims to enhance therapeutic efficacy in treating various diseases. Another notable patent involves modified AXL peptides and their use in the inhibition of AXL signaling in anti-metastatic therapy. This invention provides compositions and methods for alleviating cancer in mammals by administering a pharmaceutical composition that inhibits the activity of AXL, MER, or Tyro3 protein activity.
Career Highlights
Yu Rebecca Miao has worked with esteemed institutions such as Leland Stanford Junior University and Aravive Biologics, Inc. Her career reflects a commitment to advancing medical science through innovative research and development.
Collaborations
Miao has collaborated with notable professionals in her field, including Amato J Giaccia and Mihalis S Kariolis. These collaborations have further enriched her research and contributed to her success as an inventor.
Conclusion
Yu Rebecca Miao's contributions to biotechnology and her innovative patents demonstrate her significant role in advancing medical treatments. Her work continues to inspire future developments in the field.